SARS-CoV-2-specific immune response and the pathogenesis of COVID-19

E Gusev, A Sarapultsev, L Solomatina… - International journal of …, 2022 - mdpi.com
The review aims to consolidate research findings on the molecular mechanisms and
virulence and pathogenicity characteristics of coronavirus disease (COVID-19) causative …

Metal‐Organic Frameworks for Gene Therapy and Detection

Y He, D Li, L Wu, X Yin, X Zhang… - Advanced Functional …, 2023 - Wiley Online Library
Gene therapy holds great promise as a biomedicine for treating cancer, viral infection, and
recessive gene disorders, while genetic detection has been used for disease diagnosis and …

Neuroinflammation and Its Impact on the Pathogenesis of COVID-19

MM Almutairi, F Sivandzade, TH Albekairi… - Frontiers in …, 2021 - frontiersin.org
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). The clinical manifestations of COVID-19 …

[HTML][HTML] Biomarkers for prognosis and treatment response in COVID-19 patients

G Bivona, L Agnello, M Ciaccio - Annals of laboratory …, 2021 - synapse.koreamed.org
During a severe infection such as coronavirus disease 2019 (COVID-19), the level of almost
all analytes can change, presenting a correlation with disease severity and survival; …

miRNAs; a novel strategy for the treatment of COVID‐19

H Ying, M Ebrahimi, M Keivan… - Cell biology …, 2021 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19) is the seventh member of the bat severe
acute respiratory syndrome family. COVID‐19 can fuse their envelopes with the host cell …

Recent trends in miRNA therapeutics and the application of plant miRNA for prevention and treatment of human diseases

AN Saiyed, AR Vasavada, SRK Johar - Future Journal of Pharmaceutical …, 2022 - Springer
Background Researchers now have a new avenue to investigate when it comes to miRNA-
based therapeutics. miRNAs have the potential to be valuable biomarkers for disease …

The role of miRNAs in COVID-19 disease

M Fani, M Zandi, S Ebrahimi, S Soltani, S Abbasi - Future Virology, 2021 - Taylor & Francis
Nowadays, the SARS Coronavirus 2 (SARS-CoV-2) infection is recognized as the primary
cause of mortality in humans. SARS-CoV-2 is transmitted through human-to-human contact …

MiRNA-SARS-CoV-2 dialogue and prospective anti-COVID-19 therapies

M Panda, E Kalita, S Singh, K Kumar, A Rao… - Life Sciences, 2022 - Elsevier
COVID-19 is a highly transmissible disease caused by severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2), affects 226 countries and continents, and has resulted in> 6.2 …

Complement mediated hemolytic anemias in the COVID-19 era: case series and review of the literature

B Fattizzo, R Pasquale, V Bellani, W Barcellini… - Frontiers in …, 2021 - frontiersin.org
The complex pathophysiologic interplay between SARS-CoV-2 infection and complement
activation is the subject of active investigation. It is clinically mirrored by the occurrence of …

The regulation of lncRNAs and miRNAs in SARS-CoV-2 infection

Y Lin, Q Sun, B Zhang, W Zhao, C Shen - Frontiers in Cell and …, 2023 - frontiersin.org
The coronavirus disease 2019 (COVID-19) was a global endemic that continues to cause a
large number of severe illnesses and fatalities. There is increasing evidence that non-coding …